Protein Overexpression and Gene Amplification of c-erbB-2 in Pulmonary Carcinomas: A Comparative Immunohistochemical and Fluorescence In Situ Hybridization Study-Reference-Cited by-同舟云学术

Protein Overexpression and Gene Amplification of c-erbB-2 in Pulmonary Carcinomas: A Comparative Immunohistochemical and Fluorescence In Situ Hybridization Study

Published:2001-06 Issue:6 Volume:14 Page:556-562
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Hirashima Naoko,Takahashi Wataru,Yoshii Shinpei,Yamane Tetsu,Ooi Akishi

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3880350.pdf

Reference23 articles.

1. Hynes NE, Stern DF . The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994; 1198: 165–184.

2. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA . erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 1987; 237: 178–182.

3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182.

4. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712.

5. Meden H, Kuhn W . Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. Eur J Obstet Gynecol Repro Biol 1997; 71: 173–179.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amivantamab: A New Hope in Targeting Non-small Cell Lung Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-01

2. HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization;Balkan Medical Journal;2021-11-23

3. STUDY OF HER2 NEU POSITIVITY IN GASTROINTESTINAL CANCERS AT A TERTIARY CARE HOSPITAL IN INDIA;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2021-04-01

4. Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models;Investigational New Drugs;2021-01-03

5. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?;Oncotarget;2017-08-01